by The global cardiovascular and soft tissue repair patches market size was valued at USD 3.7 billion in 2020, and is predicted to be worth around USD 7.7 billion by 2030, registering a CAGR of 8.4% during the forecast period 2022 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39151
Table of Contents
Cardiovascular And Soft Tissue Repair Patches Market Growth Factors
The rapidly rising prevalence of congenital heart diseases, such as Atrial Septal Defect (ASD)and the ventricular septal defect is expected to drive the demand for the patches. In addition, increasing implementation of patches in medical procedures and growing sports injuries is expected to support the development and growth of the market over the forthcoming years. As per studies, ASD is the second most common type of congenital heart disease and the incidence rate across the global population is recorded to be 56 per 100,000 live births.
One of the key driving market forces is the rapidly rising prevalence of cardiovascular diseases. Changing lifestyles, growing obesity levels, adoption of unhealthy lifestyle habits, increasing alcohol consumption and smoking, and growing geriatric population are driving the incidence of cardiac disorders.
The rapidly rising incidence rate of congenital heart diseases across the globe is driving the development & growth of the market. As per data estimates on congenital heart diseases published by Centers for Disease Control and Prevention, congenital heart diseases impact nearly 1% or 40,000 live births annually in the U.S. Atrial Septal Defect (ASD) and ventricular septal defect are the two commonest congenital heart diseases.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 7.7 billion by 2030 |
| Growth Rate | CAGR of 8.4% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Application, Raw material |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Baxter; Admedus; Abbott; LeMaitre Vascular Inc.; Edwards Life Sciences Corporation; Glycar SA Pty Ltd.; LabCor; Cryolife, Inc.; CorMatrix; Terumo Medical Corporation; Bard Peripheral Vascular Inc.; Neovasc; W.L. Gore & Associates, Inc.; B.Braun; Novomedics; TEI Biosciences Inc.; Perouse Medical; Gunze Limited; Atriummed; Maverick Bioscience; Southern Lights Biomaterials |
By Application Analysis
The soft tissue segment dominated the market for cardiovascular and soft tissue repair patches and accounted for the largest revenue share of 42.0% in 2021. This is owing to the rapidly growing incidence rate of hernias including ventral hernias, umbilical hernia, inguinal hernia, congenital diaphragmatic hernia, and others coupled with the growing demand for tissue repair patches in treatment procedures.
On the other hand, the cardiac repair segment is anticipated to register the fastest growth rate in the market for cardiovascular and soft tissue repair patches over the forthcoming years. This is owing to the alarming rise of congenital heart diseases amongst the global pediatric population driving the demand for cardiac patches.
By Raw Material Analysis
The Eptfe segment dominated the cardiovascular and soft tissue repair patches market and accounted for the largest revenue share of 61.4% in 2021. This growth of the segment is owing to the multiple benefits associated with ePTFE such as high tensile strength, high durability, and easy availability.
The widespread application of ePTFE in manufacturing medical accessories such as wound care materials, transducer protectors, ostomy bags, face masks, drainage bags, urine bags, and medical device enclosures. On the other hand, the biomaterial and tissue engineered material segment is anticipated to register the fastest growth rate in the market for cardiovascular and soft tissue repair patches over the forthcoming years.
The most commonly used raw material in manufacturing cardiovascular and soft tissue repair patches is bovine pericardium and is gaining popularity. Bovine pericardium offers several physical and chemical properties which is boosting the adoption of the same.
By Regional Analysis
North America dominated the market for cardiovascular and soft tissue repair patches and accounted for the largest revenue share of 37.6% in 2021. This is owing to rapidly changing lifestyles, growing prevalence of cardiac diseases, rising number of hernia disorders, increasing alcohol consumption and smoking, growing obesity levels, and rising substance abuse.
Asia Pacific is anticipated to register the fastest growth rate over the forthcoming years owing to the rapid advancements in healthcare infrastructure, growing trends of minimally invasive surgical procedures, rising incidence of cardiac disease, growing medical tourism, rapid economic development in several countries such as China and India, growing geriatric population, and rising burden of chronic disorders.
Read also @ Liposuction Surgery Devices Market Impressive Gains by 2022-2030
Major Key Players Covered in The Cardiovascular And Soft Tissue Repair Patches Market Report include
- Baxter
- Admedus
- Abbott
- LeMaitre Vascular Inc.
- Edwards Life Sciences Corporation
- Glycar SA Pty Ltd.
- LabCor
- Cryolife, Inc.
- CorMatrix
- Terumo Medical Corporation
- Bard Peripheral Vascular Inc.
- Neovasc
- W.L. Gore & Associates, Inc.
- B.Braun
- Novomedics
- TEI Biosciences Inc.
- Perouse Medical
- Gunze Limited
- Atriummed
- Maverick Bioscience
- Southern Lights Biomaterials
Cardiovascular And Soft Tissue Repair Patches Market Segmentation
- By Application
- Cardiac repair
- Atrial septal defect
- Common atrium
- Defects of the endocardial cushion
- Ventricular septal defect
- Tetralogy of Fallot
- Right ventricular outflow tract reconstruction
- Suture bleeding
- Vascular repair & reconstruction
- Carotid endarterectomy
- Anomalous connection of the pulmonary veins
- Transposition of the great vessels
- Reconstruction of portal and superior mesenteric veins
- Other Vascular repair and reconstruction
- Pericardial repair
- Dural repair
- Soft Tissue repair
- Defects of the abdominal wall
- Defects of the thoracic wall
- Gastric binding
- Hernias
- Cardiac repair
- By Raw Materials
- ePTFE
- Biomaterial and tissue engineered material
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Spain
- France
- Italy
- Russia
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Cardiovascular And Soft Tissue Repair Patches Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Cardiovascular And Soft Tissue Repair Patches Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cardiovascular And Soft Tissue Repair Patches Market, By Application
7.1. Cardiovascular And Soft Tissue Repair Patches Market, by Application, 2021-2030
7.1.1. Cardiac repair
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Vascular repair & reconstruction
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Pericardial repair
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Dural repair
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Soft Tissue repair
7.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Cardiovascular And Soft Tissue Repair Patches Market, By Raw Material
8.1. Cardiovascular And Soft Tissue Repair Patches Market, by Raw Material, 2021-2030
8.1.1. ePTFE
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Biomaterial and tissue engineered material
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Cardiovascular And Soft Tissue Repair Patches Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2019-2030)
9.1.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.1.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.1.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.6.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.6.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.6.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.5.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.5.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
Chapter 10. Company Profiles
10.1. Baxter
10.1.1. Company Overview
10.1.2. Application Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Admedus
10.2.1. Company Overview
10.2.2. Application Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Abbott
10.3.1. Company Overview
10.3.2. Application Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. LeMaitre Vascular Inc.
10.4.1. Company Overview
10.4.2. Application Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Edwards Life Sciences Corporation
10.5.1. Company Overview
10.5.2. Application Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Glycar SA Pty Ltd.
10.6.1. Company Overview
10.6.2. Application Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. LabCor
10.7.1. Company Overview
10.7.2. Application Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Cryolife, Inc.
10.8.1. Company Overview
10.8.2. Application Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. CorMatrix
10.9.1. Company Overview
10.9.2. Application Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Terumo Medical Corporation
10.10.1. Company Overview
10.10.2. Application Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39151
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
